IA
SGTX

IFP Advisors’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

IFP Advisors’s Portfolio SGTX Stock Details SGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-200
Closed -$4.49K – 3423
2023
Q3 		$4.49K Buy
+200
New +$4.33K ﹤0.01% 2553

IFP Advisors's SGTX Position: Q4 2023 in Review

IFP Advisors sold out of Sigilon Therapeutics, Inc. Common Stock (SGTX) in Q4 2023, closing a stake of 200 shares — an estimated $4.49K sold.

IFP Advisors first reported a position in SGTX in Q3 2023 and held it in 1 quarter. The position peaked at $4.49K in Q3 2023. 0 funds tracked by Wall St. Rank hold SGTX as of Q4 2023.

  • IFP Advisors reported no remaining Sigilon Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • IFP Advisors sold 200 Sigilon Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $4.49K.
  • IFP Advisors first reported a position in Sigilon Therapeutics, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • IFP Advisors's Sigilon Therapeutics, Inc. Common Stock position peaked at $4.49K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Sigilon Therapeutics, Inc. Common Stock as of Q4 2023.

Based on IFP Advisors's 13F filing for Q4 2023, filed 9 Jan 2024.